198 related articles for article (PubMed ID: 10541904)
1. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis.
Fukai T; Okada AA; Sakai J; Kezuka T; Keino H; Usui M; Yagita H; Okumura K; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):928-33. PubMed ID: 10541904
[TBL] [Abstract][Full Text] [Related]
2. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance.
Silver PB; Hathcock KS; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(9):5041-7. PubMed ID: 11046033
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
[TBL] [Abstract][Full Text] [Related]
4. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
Ando K; Fujino Y; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
[TBL] [Abstract][Full Text] [Related]
6. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
7. Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis.
Busch M; Bauer D; Hennig M; Wasmuth S; Thanos S; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):39-46. PubMed ID: 23211816
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
[TBL] [Abstract][Full Text] [Related]
9. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
[TBL] [Abstract][Full Text] [Related]
10. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
12. Effect of type I interferon on experimental autoimmune uveoretinitis in rats.
Okada AA; Keino H; Fukai T; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Dec; 6(4):215-26. PubMed ID: 9924918
[TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
Kawashima H; Fujiño Y; Mochizuki M
Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
[TBL] [Abstract][Full Text] [Related]
16. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
Jiang HR; Lumsden L; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
[TBL] [Abstract][Full Text] [Related]
17. Everolimus improves experimental autoimmune uveoretinitis.
Hennig M; Bauer D; Wasmuth S; Busch M; Walscheid K; Thanos S; Heiligenhaus A
Exp Eye Res; 2012 Dec; 105():43-52. PubMed ID: 23059401
[TBL] [Abstract][Full Text] [Related]
18. Murine experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein and Klebsiella pneumoniae 03 lipopolysaccharide (K03-LPS): a relation between H-2 haplotype and EAU induction.
Ando K; Yamamoto JH; Fujino Y; Kato N; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 1994 Feb; 232(2):127-31. PubMed ID: 8157176
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
20. [Translational research with experimental autoimmune uveoretinitis (EAU)].
Usui M
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):137-58; discussion 159. PubMed ID: 17402560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
